Insider · CIK 0001506217

Fyfe Gwen A.

Reports to the SEC for 4 companies · SUNNYVALE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001506217

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-07-30	ARRAY BIOPHARMA INCD Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCD Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	$48.00	−$720K	5,000
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2018-10-26	ARRAY BIOPHARMA INCM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	—	—	15,000
2018-10-26	ARRAY BIOPHARMA INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2018-10-25	ARRAY BIOPHARMA INCStock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2018-10-25	ARRAY BIOPHARMA INCRestricted Stock UnitsA Award	Director	AAward	+5,000 sh	—	—	5,000
2018-03-09	Cascadian Therapeutics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−10.1K sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−13.9K sh	—	—	0
2017-10-27	ARRAY BIOPHARMA INCM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$10.47	+$52.4K	10,000
2017-10-27	ARRAY BIOPHARMA INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2017-10-26	ARRAY BIOPHARMA INCRestricted Stock UnitsA Award	Director	AAward	+5,000 sh	—	—	5,000
2017-10-26	ARRAY BIOPHARMA INCStock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2017-06-24	Cascadian Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−2,265 sh	$3.78	−$8,561.7	10,125
2017-06-24	Cascadian Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,058 sh	—	—	12,390
2017-06-24	Cascadian Therapeutics, Inc.Restricted Share Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	−9,058 sh	—	—	0
2017-06-09	Cascadian Therapeutics, Inc.Restricted Share Unit (RSU)A Award	Director	AAward	+13.9K sh	—	—	13,927
2017-03-28	Cascadian Therapeutics, Inc.P Purchase	Director	PPurchase	+1,666 sh	$4.12	+$6,856.923	3,332
2016-10-29	ARRAY BIOPHARMA INCM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$5.83	+$29.2K	5,000
2016-10-29	ARRAY BIOPHARMA INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2016-10-27	ARRAY BIOPHARMA INCRestricted Stock UnitsA Award	Director	AAward	+5,000 sh	—	—	5,000
2016-10-27	ARRAY BIOPHARMA INCStock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2016-06-24	Cascadian Therapeutics, Inc.Restricted Share Unit (RSU)A Award	Director	AAward	+54.3K sh	—	—	54,347
2015-10-29	ARRAY BIOPHARMA INCRestricted Stock UnitsA Award	Director	AAward	+5,000 sh	—	—	5,000
2015-10-29	ARRAY BIOPHARMA INCStock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2015-06-15	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2014-10-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2013-10-23	ARRAY BIOPHARMA INCStock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2013-06-11	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2012-10-24	ARRAY BIOPHARMA INCStock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2012-05-16	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2012-03-08	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2012-02-09	ARRAY BIOPHARMA INCStock Option (Right to Buy)A Award	Director	AAward	+20K sh	$2.60	+$52K	20,000
2011-10-03	PHARMACYCLICS INCNon-qualified Stock Option (right to buy)A Award	Director	AAward	+2,652 sh	—	—	2,652
2011-07-01	PHARMACYCLICS INCNon-qualified Stock Option (right to buy)A Award	Director	AAward	+2,126 sh	—	—	2,126
2011-04-01	PHARMACYCLICS INCNon-qualified Stock Option (right to buy)A Award	Director	AAward	+3,743 sh	—	—	3,743
2010-12-13	PHARMACYCLICS INCNon-qualified Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2010-12-09	PHARMACYCLICS INCNon-qualified Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000

Recent filings

Accepted (ET)
Jul 304
Fyfe Gwen A.0001209191-19-043778
SEC(opens sec.gov)
Oct 294
Fyfe Gwen A.0001562180-18-004314
SEC(opens sec.gov)
Mar 134
Fyfe Gwen A.0000899243-18-007306
SEC(opens sec.gov)
Oct 274
Fyfe Gwen A.0001562180-17-003341
SEC(opens sec.gov)

Companies

Address

995 EAST ARQUES AVENUE

SUNNYVALE, CA, 94085